|
ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor
|
5R00CA158065-05
|
$249,000
|
$249,000
|
RINK, LORI
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$73,642
|
$44,185
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Yale Cancer Center NCTN
|
5U10CA180826-03
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
3U10CA180833-02S1
|
$100,000
|
$5,000
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-03
|
$1,649,280
|
$82,464
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Viral Oncology Training Grant
|
5T32CA009111-38
|
$378,220
|
$37,822
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Using zebrafish to study the role of six1a/b and microRNA-30a in rhabdomyosarcoma (RMS) initiation and progression
|
1R21CA201809-01A1
|
$169,106
|
$169,106
|
FORD, HEIDE
|
UNIVERSITY OF COLORADO DENVER
|
|
Using CRISPR/Cas9 to dissect the role of FUS-CHOP in tumor response to radiation therapy
|
1F30CA206424-01
|
$37,176
|
$37,176
|
CHEN, MARK
|
DUKE UNIVERSITY
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$24,782
|
$24,782
|
Merlino, Glenn
|
CCR (NCI)
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
2P30CA014089-41
|
$6,354,897
|
$762,588
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S1
|
$59,999
|
$7,200
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S2
|
$37,500
|
$4,500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
7K01CA184388-03
|
$108,808
|
$108,808
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
2P30CA134274-09
|
$2,259,773
|
$45,195
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S1
|
$124,964
|
$2,499
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S2
|
$200,219
|
$4,004
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S3
|
$629,550
|
$12,591
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Colorado NTCN Lead Academic Participating Site (LAPS)
|
5U10CA180834-03
|
$768,950
|
$38,448
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Underlying Mechanisms in Angiosarcoma
|
5R01CA197943-02
|
$352,275
|
$352,275
|
IRUELA-ARISPE, M
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-Associated Cancer
|
5U54CA190153-03
|
$672,287
|
$410,095
|
MARTIN, JEFFREY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
|
1R01CA200574-01A1
|
$372,888
|
$372,888
|
ZHANG, LIANGFANG
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
TUMOR-IMPOSED GLUCOSE RESTRICTIONS ON T CELLS DAMPEN IMMUNITY
|
5R01CA181125-03
|
$224,100
|
$224,100
|
PEARCE, ERIKA
|
INSTITUT FUR IMMUNBIOLOGIE/EPIGENETIK
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$353,472
|
$116,646
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Tumor and Metastasis Biology
|
ZIA BC 010566
|
$119,127
|
$119,127
|
Helman, Lee
|
CCR (NCI)
|
|
Thrombocytes in Cancer Immunity
|
5R01CA188419-02
|
$387,236
|
$96,809
|
LI, ZIHAI
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Three-dimensional, mechanically tunable scaffold systems to model osteosarcoma heterogeneity and therapeutic response
|
1F31CA213994-01
|
$43,576
|
$43,576
|
MOLINA, ERIC
|
RICE UNIVERSITY
|
|
Three-dimensional Model of Human Ewing Sarcoma
|
5R01CA180279-03
|
$322,736
|
$322,736
|
MIKOS, ANTONIOS
|
RICE UNIVERSITY
|
|
Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes
|
ZIA BC 010801
|
$689,174
|
$172,293
|
Widemann, Brigitte
|
CCR (NCI)
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
5P30CA196521-02
|
$2,373,000
|
$23,730
|
BURAKOFF, STEVEN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-22S1
|
$79,482
|
$795
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-22S2
|
$202,481
|
$2,025
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
4P30CA060553-22
|
$4,865,180
|
$48,652
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Johns Hopkins Physical Sciences Oncology Center
|
1U54CA210173-01
|
$1,933,384
|
$483,346
|
WIRTZ, DENIS
|
JOHNS HOPKINS UNIVERSITY
|
|
The histone demethylase KDM3A upregulates MCAM to promote Ewing Sarcoma metastasis
|
1F31CA203053-01
|
$32,837
|
$32,837
|
SECHLER, MARYBETH
|
UNIVERSITY OF COLORADO DENVER
|
|
The CARMA3/Bcl10/MALT1 signalosome in osteosarcoma metastasis
|
1F30CA196095-01A1
|
$48,576
|
$48,576
|
MCAULEY, JAMES
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
The 19th International Workshop on KSHV and Related Agents
|
1R13CA210906-01
|
$5,000
|
$5,000
|
FENG, PINGHUI
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
TGIB Surgical Oncology Fellowship Program
|
ZIE BC 011542
|
$1,075,385
|
$107,538
|
Schrump, David
|
CCR (NCI)
|
|
TGIB Surgical Consultative Services
|
ZID BC 011541
|
$2,048,352
|
$204,835
|
Schrump, David
|
CCR (NCI)
|
|
Testicular effects of modern chemotherapy regimens in osteosarcoma survivors
|
1R01CA175216-01A1
|
$699,129
|
$699,129
|
SHNORHAVORIAN, MARGARETT
|
SEATTLE CHILDREN'S HOSPITAL
|
|
Targeting vismodegib-resistant tumors using BH3 mimetics
|
1R01CA196851-01A1
|
$346,539
|
$173,270
|
LUM, LAWRENCE
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-03
|
$435,560
|
$435,560
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Targeting Tumor Cell Iron Addiction to Achieve Tumor-Selective Cell Death
|
5R00CA166517-05
|
$230,322
|
$57,581
|
DIXON, SCOTT
|
STANFORD UNIVERSITY
|
|
Targeting of Genes in the Mammalian Genome
|
9R01CA210165-41A1
|
$468,711
|
$468,711
|
CAPECCHI, MARIO
|
UNIVERSITY OF UTAH
|
|
Targeting KSHV malignancies and persistent infection
|
5R01CA197153-02
|
$377,438
|
$377,438
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Targeting insulin receptor splicing for treatment of rhabdomyosarcoma
|
1R21CA195324-01A1
|
$196,022
|
$196,022
|
CHANDLER, DAWN
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma
|
ZIA BC 010999
|
$526,915
|
$421,532
|
Khan, Javed
|
CCR (NCI)
|
|
Targeting FAK and integrin signaling in preclinical models of Ewing sarcoma
|
5K08CA188073-02
|
$177,120
|
$177,120
|
CROMPTON, BRIAN
|
DANA-FARBER CANCER INST
|
|
Targeting CXCR4 and microRNA as Therapy for Chondrosarcoma
|
4R01CA166089-04
|
$280,000
|
$280,000
|
TEREK, RICHARD
|
RHODE ISLAND HOSPITAL
|
|
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
|
2R01CA163217-06
|
$342,759
|
$171,380
|
DITTMER, DIRK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
System analysis of p53 mutant associated cancer development with LFS patient- specific iPSCs
|
1F99CA212489-01
|
$45,076
|
$29,750
|
KIM, HUEN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
Total relevant funding to Sarcoma for this search: $77,110,724
|